isn’t this what the rest of us call fampridine, or 4-ap, and which some of us have been taking for months, if not more? tart it up with a new name, get the fda involved, and before long, someone (Acorda Therapeutics) is going to be making a lot of money off this. “the drug — tentatively named Ampriva — would be the first to improve nervous system function in people suffering from the devastating disease.” not true. fampridine has been around for years(?) this ampriva is NOT the first. shameful. no wonder out healthcare system is in such a shambles.
Share this Post
November 11, 2009 at 7:18 pm
I read the article on Examiner.com. What a sloppy piece of writing, based off the WebMD article.
But I have to admit that this is the first time I’ve seen the NEW suggested brand name for the drug. In October, it was proposed to be Amaya. And now it’s Ampriva? I did think that Amaya didn’t make any sense, but Ampriva at least seems tied to Fampridine-SR which is 4-aminopyridine.
Now the only big question which remains is: after Ampriva gets FDA approval, will the compounding pharmacies continue to make 4-aminopyridine?
If you are curious about the history of Acorda and Fampridine, I wrote extensively about them last summer on my blog.
November 11, 2009 at 11:38 pm
I’ve also heard the “new” name is Amaya. FDA was set to make a decision on it on Oct. 22 but put it off until Jan. 22 because Acorda submitted additional info on it that requires evaluation.
You’re right, it is a form of 4-AP which has been around for years. But many docs, my own included, won’t Rx it until it’s a marketable (read $$$ involved), bonafide drug for human consumption. The advantage is, many people will finally be able to give it a go…
You’re on it?? Does it help?? Just askin’…!